These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 9126332)

  • 1. Mapping of the extracellular binding regions of the human interleukin-8 type B receptor.
    Katancik JA; Sharma A; Radel SJ; De Nardin E
    Biochem Biophys Res Commun; 1997 Mar; 232(3):663-8. PubMed ID: 9126332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin 8, neutrophil-activating peptide-2 and GRO-alpha bind to and elicit cell activation via specific and different amino acid residues of CXCR2.
    Katancik JA; Sharma A; de Nardin E
    Cytokine; 2000 Oct; 12(10):1480-8. PubMed ID: 11023662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional and ligand binding specificity of the rabbit neutrophil IL-8 receptor.
    Thomas KM; Taylor L; Prado G; Romero J; Moser B; Car B; Walz A; Baggiolini M; Navarro J
    J Immunol; 1994 Mar; 152(5):2496-500. PubMed ID: 8133060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CXC chemokines bind to unique sets of selectivity determinants that can function independently and are broadly distributed on multiple domains of human interleukin-8 receptor B. Determinants of high affinity binding and receptor activation are distinct.
    Ahuja SK; Lee JC; Murphy PM
    J Biol Chem; 1996 Jan; 271(1):225-32. PubMed ID: 8550564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple sites on IL-8 responsible for binding to alpha and beta IL-8 receptors.
    Schraufstätter IU; Barritt DS; Ma M; Oades ZG; Cochrane CG
    J Immunol; 1993 Dec; 151(11):6418-28. PubMed ID: 8245475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and functional activity of the IL-8 receptor type CXCR1 and CXCR2 on human mast cells.
    Lippert U; Artuc M; Grützkau A; Möller A; Kenderessy-Szabo A; Schadendorf D; Norgauer J; Hartmann K; Schweitzer-Stenner R; Zuberbier T; Henz BM; Krüger-Krasagakes S
    J Immunol; 1998 Sep; 161(5):2600-8. PubMed ID: 9725262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional and receptor binding characterization of recombinant murine macrophage inflammatory protein 2: sequence analysis and mutagenesis identify receptor binding epitopes.
    Jerva LF; Sullivan G; Lolis E
    Protein Sci; 1997 Aug; 6(8):1643-52. PubMed ID: 9260277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interruption of G protein-coupling in CXCR2 does not alter ligand binding, but eliminates ligand-activation of GTPgamma35S binding, calcium mobilization, and chemotaxis.
    Yang W; Schraw WP; Mueller SG; Richmond A
    Biochemistry; 1997 Dec; 36(49):15193-200. PubMed ID: 9398246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutrophils regulate their own apoptosis via preservation of CXC receptors.
    Dunican A; Grutkoski P; Leuenroth S; Ayala A; Simms HH
    J Surg Res; 2000 May; 90(1):32-8. PubMed ID: 10781372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A His19 to Ala mutant of melanoma growth-stimulating activity is a partial antagonist of the CXCR2 receptor.
    Baly DL; Horuk R; Yansura DG; Simmons LC; Fairbrother WJ; Kotts C; Wirth CM; Gillece-Castro BL; Toy K; Hesselgesser J; Allison DE
    J Immunol; 1998 Nov; 161(9):4944-9. PubMed ID: 9794430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-8 and NAP-2 differ in their capacities to bind and chemoattract 293 cells transfected with either IL-8 receptor type A or type B.
    Ben-Baruch A; Bengali K; Tani K; Xu L; Oppenheim JJ; Wang JM
    Cytokine; 1997 Jan; 9(1):37-45. PubMed ID: 9067094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The CXC chemokines growth-regulated oncogene (GRO) alpha, GRObeta, GROgamma, neutrophil-activating peptide-2, and epithelial cell-derived neutrophil-activating peptide-78 are potent agonists for the type B, but not the type A, human interleukin-8 receptor.
    Ahuja SK; Murphy PM
    J Biol Chem; 1996 Aug; 271(34):20545-50. PubMed ID: 8702798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and growth-promoting function of the IL-8 receptor beta in human melanoma cells.
    Norgauer J; Metzner B; Schraufstätter I
    J Immunol; 1996 Feb; 156(3):1132-37. PubMed ID: 8557989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exchanging interleukin-8 and melanoma growth-stimulating activity receptor binding specificities.
    Lowman HB; Slagle PH; DeForge LE; Wirth CM; Gillece-Castro BL; Bourell JH; Fairbrother WJ
    J Biol Chem; 1996 Jun; 271(24):14344-52. PubMed ID: 8662882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High- and low-affinity binding of GRO alpha and neutrophil-activating peptide 2 to interleukin 8 receptors on human neutrophils.
    Schumacher C; Clark-Lewis I; Baggiolini M; Moser B
    Proc Natl Acad Sci U S A; 1992 Nov; 89(21):10542-6. PubMed ID: 1438244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reconstitution of chemokine-induced actin polymerization in undifferentiated human leukemia cells (HL-60) by heterologous expression of interleukin-8 receptors.
    Norgauer J; Metzner B; Czech W; Schraufstatter I
    Inflamm Res; 1996 Mar; 45(3):127-31. PubMed ID: 8689391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Receptor recognition and specificity of interleukin-8 is determined by residues that cluster near a surface-accessible hydrophobic pocket.
    Hammond ME; Shyamala V; Siani MA; Gallegos CA; Feucht PH; Abbott J; Lapointe GR; Moghadam M; Khoja H; Zakel J; Tekamp-Olson P
    J Biol Chem; 1996 Apr; 271(14):8228-35. PubMed ID: 8626516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Receptor binding specificity and pulmonary gene expression of the neutrophil-activating peptide ENA-78.
    Bozic CR; Gerard NP; Gerard C
    Am J Respir Cell Mol Biol; 1996 Mar; 14(3):302-8. PubMed ID: 8845182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular characterization of the chemokine receptor CXCR3: evidence for the involvement of distinct extracellular domains in a multi-step model of ligand binding and receptor activation.
    Xanthou G; Williams TJ; Pease JE
    Eur J Immunol; 2003 Oct; 33(10):2927-36. PubMed ID: 14515277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular characterization of receptors for human interleukin-8, GRO/melanoma growth-stimulatory activity and neutrophil activating peptide-2.
    Cerretti DP; Kozlosky CJ; Vanden Bos T; Nelson N; Gearing DP; Beckmann MP
    Mol Immunol; 1993 Mar; 30(4):359-67. PubMed ID: 8384312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.